Potential application of Nardostachyos Radix et Rhizoma-Rhubarb for the treatment of diabetic kidney disease based on network pharmacology and cell culture experimental verification

doi:10.4239/wjd.v15.i3.530

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1543)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series.

Item

Count

PDF

WORD

HTML

1022

Figures (1-7)

129

Sum=1241

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

140

Sum=224

Mar 15, 2024 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Mar 15, 2024; 15(3): 530-551
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.530

Full Size Figure Download Figure

Figure 1 Flow chart of network pharmacological prediction and experimental validation. GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; DKD: Diabetic kidney disease; PPI: Protein-protein interaction; BP: Biological process; CC: Cell composition; MF: Molecular function; IC₅₀: Half maximal inhibitory concentration.

Citation: Che MY, Yuan L, Min J, Xu DJ, Lu DD, Liu WJ, Wang KL, Wang YY, Nan Y. Potential application of Nardostachyos Radix et Rhizoma-Rhubarb for the treatment of diabetic kidney disease based on network pharmacology and cell culture experimental verification. World J Diabetes 2024; 15(3): 530-551
URL: https://www.wjgnet.com/1948-9358/full/v15/i3/530.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i3.530